As activation of RORα by an inhibitor has an important impact on the treatment of solid tumors via the regulation of cholesterol metabolism, the discovery of our epigenetic control of the tumor environment will greatly advance our understanding of therapeutic strategies in cancer treatment, including colon cancers. This evidence concerns the gene RORA and malignant colon neoplasm.